Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: Possible relevance to multiple sclerosis

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 115-122

  Malamud, Vivian ^a   Vaaknin, Ady ^b   Abramsky, Oded ^b   Mor, Michal ^b   Burgess, Laurence E ^c   Ben Yehudah, Ahmi ^a   Lorberboum Galski, Haya ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c ARRAY BIOPHARMA INC   (United States)

Author keywords

Cytokines; Multiple sclerosis; Peripheral blood mononuclear cells; Tryptase

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0037960323     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00090-0     Document Type: Article

References (45)

1. Asokananthan N., Graham P.T., Fink J., Knight D.A., Bakker A.J., McWilliam A.S., Thompson P.J., Stewart G.A. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J. Immunol. 168:2002;3577-3585.
2. Bebo B.F., Yong J.T., Orr E.L., Linthicum D.S. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;340-348.
3. Brod S.A., Marshall G.D. Jr., Henninger E.M., Sriram S., Khan M., Wolinsky J.S. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology. 46:1996;1633-1638.
4. Brown J.K., Tyler C.L., Jones C.A., Ruoss S.J., Hartmann T., Caughey G.H. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13:1995;227-236.
5. Burgess L.E., Newhouse B.J., Ibrahim P., Rizzi J., Kashem M.A., Hartman A., Brandhuber B.J., Wright C.D., Thomson D.S., Vigers G.P., Koch K. Potent selective nonpeptidic inhibitors of human lung tryptase. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8348-8352.
6. Cairns J.A., Walls A.F. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156:1996;275-283.
7. Cairns J.A., Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99:1997;1313-1321.
8. Clerici M., Saresella M., Trabattoni D., Speciale L., Fossati S., Ruzzante S., Cavaretta R., Filippi M., Caputo D., Ferrante P. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J. Neuroimmunol. 121:2001;88-101.
9. Compton S.J., Cairns J.A., Holgate S.T., Walls A.F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1b and IL-8 and stimulates the selective release of IL-8 from umbilical vein endothelial cells. J. Immunol. 161:1998;1939-1946.
10. Corvera C.U., Dery O., McConalogue K., Bohm S.K., Khitin L.M., Caughey G.H., Payan D.G., Bunnett N.W. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J. Clin. Invest. 100:1997;1383-1393.
11. Corvera C.U., Dery O., McConalogue K., Gamp P., Thoma M., Al-Ani B., Caughey G.H., Hollenberg M.D., Bunnett N.W. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J. Physiol. (Lond.). 517:1999;741-756.
12. Dery O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274:1998;C1429-C1452.
13. Dhib-Jalbut S. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Neurology. 58:2002;S3-S9.
14. Dietsch G.N., Hinrichs D.J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142:1989;1476-1481.
15. Dietsch G.N., Hinrichs D.J. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135:1991;541-548.
16. Dimitriadoua V., Pangb X., Theoaridesa T.C. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int. J. Immunopharmacol. 22:2000;673-684.
17. Dines K.C., Powell H.C. Mast cell interactions with nervous system: relationship with mechanisms of disease. J. Neuropathol. Exp. Neurol. 56:1997;627-640.
18. Ewing C., Bernaed C.C. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol. Cell Biol. 76:1998;47-54.
19. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S., Schwartz L.B., Korn J.H. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid and fibroblast chemotaxis. J. Immunol. 158:1997;2310-2317.
20. Iarlori C., Reale M., Lugaresi A., De Luca G., Bonanni L., Di Iorio A., Feliciani C., Conti P., Gambi D. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b. J. Neuroimmunol. 107:2000;100-107.
21. Ibrahim M.Z.M., Reder A.T., Lawand R., Takash W., Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
22. Johnson D., Seeldrayers P.A., Weiner H.L. The role of mast cells in demyelination: 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 44:1988;195-198.
23. Kostyk S.K., Kowall N.W., Hauser S.L. Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Res. 504:1988;284-288.
24. Kruger P.G. Mast cells and multiple sclerosis: a quantitative analysis. Neuropathol. Appl. Neurobiol. 27:2001;275-280.
25. Kruger P.G., Bo L., Myhr K.M., Karlsen A.E., Taule A., Nyland H.I., Mork S. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol. Scand. 81:1990;31-36.
26. Macey M.G. The protease-activated receptors and their cellular expression and function in blood-related cells. Br. J. Haematol. 101:1998;1-9.
27. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., Poliani P.L., Grimaldi L.M., Comi G. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 109:2000;3-9.
28. Miller A., Shapiro S., Gershtein R., Kinarty A., Rawashdeh H., Honigman S., Lahat N. Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J. Neuroimmunol. 92:1998;113-121.
29. Mirza H., Schmidt V.A., Derian C.K., Jesty J., Bahou W.F. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood. 90:1997;3914-3922.
30. Munoz-Fernandez M.A., Fresno M. The role of tumour necrosis factor, interleukin 6, interferon- and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56:1998;307-340.
31. Navikas V., Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
32. Neumann J. Uber das Varkommen der sogenannten 'Mastzellen' bei pathologischen Veranderungen des Gehirns. Virchows Arch. Pathol. Anat. 122:1890;378-381.
33. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
34. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23:2000;618-625.
35. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
36. Ruoss S.J., Hartmann T., Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88:1991;493-499.
37. Secor V.H., Evan Secor W., Gutekunst C., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:2000;813-821.
38. Sommerhoff C.P., Bode W., Matschiner G., Bergner A., Fritz H. The human mast cell tryptase tetramer: a fascinating riddle solved by structure. Biochim. Biophys. Acta. 1477:2000;75-89.
39. Sorensen T.L., Sellebjerg F. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology. 57:2001;1371-1376.
40. Stinissen P., Raus J., Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit. Rev. Immunol. 17:1997;33-75.
41. Vliagoftis H., Befus A.D., Hollenberg M.D., Moqbel R. Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2. J. Allergy Clin. Immunol. 107:2001;679-685.
42. Wang X., Chen M., Wandinger K.P., Williams G., Dhib-Jalbut S. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis. J. Immunol. 165:2000;548-557.
43. Weiner H.L., Cohen J.A. Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects. Mult. Scler. 8:2002;142-154.
44. Wright C.D., Havill A.M., Middleton S.C., Kashem M.A., Dripps D.J., Abraham W.M., Thomson D.S., Burgess L.E. Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-{4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy}-pentane (AMG-126737). Biochem. Pharmacol. 58:1999;1989-1996.
45. Xu W.F., Andersen H., Presnell S.R., Yee D.P., Gilbert T., Davie E.W., Foster D.C. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6642-6646.